Serendip

Our mission is to unlock the full therapeutic potential of RNA medicines beyond the limitations of conventional lipid nanoparticles (LNPs) and IVT RNA technologies. Serendip Innovations is developing a next-generation RNA platform that integrates both RNA manufacturing and targeted delivery. Using a unique plant-based production system and phytovirus-like particles (phytoVLP), we generate functional long RNAs directly encapsulated into a proprietary non-viral vector designed for targeted extrahepatic delivery, repeat dosing, and scalable manufacturing. One convenient platform, one co-development and licensing partnership. Plant-based production brings more than the capacity of producing high added-value drug products. It brings less CO2 for the environment, cost affordability for therapy developers and patients.